Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Boonen

Showing results (71-80 of 107) with videos related to

Pageof 11
Sort By:
Annals of the Rheumatic Diseases|October 17, 2001
Withdrawal from labour force due to work disability in patients with ankylosing spondylitisA Boonen, A Chorus, H Miedema, et al.
Annals of the Rheumatic Diseases|July 24, 2004
Large differences in cost of illness and wellbeing between patients with fibromyalgia, chronic low back pain, or ankylosing spondylitisA Boonen, R van den Heuvel, A van Tubergen, et al.
Osteoarthritis and Cartilage|August 13, 2018
Performance of the Michigan Hand Outcomes Questionnaire in hand osteoarthritisF P B Kroon, A Boersma, A Boonen, et al.
Annals of the Rheumatic Diseases|September 14, 2004
Is avoidant coping independent of disease status and stable over time in patients with ankylosing spondylitis?A Boonen, D Van Der Heijde, R Landewé, et al.
Annals of the Rheumatic Diseases|July 15, 2005
Markov model into the cost-utility over five years of etanercept and infliximab compared with usual care in patients with active ankylosing spondylitisA Boonen, D van der Heijde, J L Severens, et al.
Annals of the Rheumatic Diseases|March 14, 2009
ASAS/WHO ICF Core Sets for ankylosing spondylitis (AS): how to classify the impact of AS on functioning and healthA Boonen, J Braun, I E van der Horst Bruinsma, et al.
Annals of the Rheumatic Diseases|December 19, 2006
Utility and direct costs: ankylosing spondylitis compared with rheumatoid arthritisS M M Verstappen, J W G Jacobs, D M van der Heijde, et al.
Annals of the Rheumatic Diseases|November 21, 2008
Erosive progression is minimal, but erosion healing rare, in patients with rheumatoid arthritis treated with adalimumab. A 1 year investigator-initiated follow-up study using high-resolution computed tomography as the primary outcome measureU Møller Døhn, A Boonen, M L Hetland, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 26, 2022
Patient preferences for lifestyle behaviours in osteoporotic fracture prevention: a cross-European discrete choice experimentC Beaudart, A Boonen, N Li, et al.
The Journal of Rheumatology|May 1, 2001
Minimal clinically important difference in radiological progression of joint damage over 1 year in rheumatoid arthritis: preliminary results of a validation study with clinical expertsK Bruynesteyn, D van der Heijde, M Boers, et al.
Pageof 11

Showing results (71-80 of 107) with videos related to

Sort By:
Pageof 11
Annals of the Rheumatic Diseases|October 17, 2001
Withdrawal from labour force due to work disability in patients with ankylosing spondylitisA Boonen, A Chorus, H Miedema, et al.
Annals of the Rheumatic Diseases|July 24, 2004
Large differences in cost of illness and wellbeing between patients with fibromyalgia, chronic low back pain, or ankylosing spondylitisA Boonen, R van den Heuvel, A van Tubergen, et al.
Osteoarthritis and Cartilage|August 13, 2018
Performance of the Michigan Hand Outcomes Questionnaire in hand osteoarthritisF P B Kroon, A Boersma, A Boonen, et al.
Annals of the Rheumatic Diseases|September 14, 2004
Is avoidant coping independent of disease status and stable over time in patients with ankylosing spondylitis?A Boonen, D Van Der Heijde, R Landewé, et al.
Annals of the Rheumatic Diseases|July 15, 2005
Markov model into the cost-utility over five years of etanercept and infliximab compared with usual care in patients with active ankylosing spondylitisA Boonen, D van der Heijde, J L Severens, et al.
Annals of the Rheumatic Diseases|March 14, 2009
ASAS/WHO ICF Core Sets for ankylosing spondylitis (AS): how to classify the impact of AS on functioning and healthA Boonen, J Braun, I E van der Horst Bruinsma, et al.
Annals of the Rheumatic Diseases|December 19, 2006
Utility and direct costs: ankylosing spondylitis compared with rheumatoid arthritisS M M Verstappen, J W G Jacobs, D M van der Heijde, et al.
Annals of the Rheumatic Diseases|November 21, 2008
Erosive progression is minimal, but erosion healing rare, in patients with rheumatoid arthritis treated with adalimumab. A 1 year investigator-initiated follow-up study using high-resolution computed tomography as the primary outcome measureU Møller Døhn, A Boonen, M L Hetland, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 26, 2022
Patient preferences for lifestyle behaviours in osteoporotic fracture prevention: a cross-European discrete choice experimentC Beaudart, A Boonen, N Li, et al.
The Journal of Rheumatology|May 1, 2001
Minimal clinically important difference in radiological progression of joint damage over 1 year in rheumatoid arthritis: preliminary results of a validation study with clinical expertsK Bruynesteyn, D van der Heijde, M Boers, et al.
Pageof 11